European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 707-709 , September 2006

Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer

  • K. McCarthy

      Affiliations

    • Breast Unit, St Bartholomew's Hospital, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    • ,
  • S.A. Bustin

      Affiliations

    • Centre for Academic Surgery, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London E1 1BD, UK
    • ,
  • B. Ogunkolade

      Affiliations

    • Centre for Academic Surgery, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London E1 1BD, UK
    • ,
  • S. Khalaf

      Affiliations

    • Centre for Academic Surgery, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London E1 1BD, UK
    • ,
  • C.A. Laban

      Affiliations

    • Breast Unit, St Bartholomew's Hospital, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    • ,
  • C.J. McVittie

      Affiliations

    • Breast Unit, St Bartholomew's Hospital, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    • ,
  • R. Carpenter

      Affiliations

    • Breast Unit, St Bartholomew's Hospital, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    • ,
  • P.J. Jenkins

      Affiliations

    • Department of Endocrinology, St Bartholomew's Hospital, Barts and The London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 601 8343; fax: +44 207 601 8505.

,Accepted 17 February 2006.

References 

  1. Gupta RA, DuBois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2001 October;1(1):11–21
  2. Hull MA. Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?. Eur J Cancer. 2005 September;41(13):1854–1863
  3. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst. 1996 July 17;88(14):988–993
  4. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989 November 18;299(6710):1247–1250
  5. Thun MJ, Namboodiri MM, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 December 5;325(23):1593–1596
  6. Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 1996 March;7(2):203–205
  7. Friedman GD, Ury HK. Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst. 1980 October;65(4):723–733
  8. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994 March;5(2):138–146
  9. Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer. 2000 July;83(1):112–120
  10. Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer. 2001 May 4;84(9):1188–1192
  11. Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, et al. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett. 1998 January 9;122(1–2):165–175
  12. Lala PK, Al Mutter N, Orucevic A. Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer. 1997 November 4;73(3):371–380
  13. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer. 2001 June;8(2):97–114
  14. Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett. 1999 June 1;140(1–2):27–35
  15. Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002 February 1;62(3):632–635
  16. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998 March 18;90(6):455–460
  17. Bennett A, Berstock DA, Carroll MA, Stamford IF, Wilson AJ. Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:299–302
  18. Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 2002 March 15;62(6):1676–1681
  19. Singh-Ranger G, Kirkpatrick KL, Clark GM, Mokbel K. Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Curr Med Res Opin. 2003;19(2):131–134
  20. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002 June;55(6):429–434
  21. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000 December 15;89(12):2637–2645
  22. Gilhooly EM, Rose DP. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol. 1999 August;15(2):267–270
  23. Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, et al. HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. Clin Cancer Res. 2004 September 1;10(17):5670–5676

PII: S0748-7983(06)00109-0

doi: 10.1016/j.ejso.2006.02.024

European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 707-709 , September 2006

Article Tools